GoldenNeuro is creating next-generation genetic therapies by selecting therapeutic cargos and designing delivery technologies for the needs of disease targets—currently, Parkinson’s Disease.
Our vision is to bring biomedical breakthroughs to the global healthcare community
Our mission is to prove the effectiveness of our drug delivery approach before pursuing external support. We do not settle for easy to transfect cell lines!
GoldenNeuro is led by a seasoned team with decades of experience in biopharma and biomedical science, bringing together deep expertise, inventive problem-solving, and a strong track record in delivery technologies — including peer-reviewed publications, patents, and commercial products.
We have a fully equipped state of the art biopharm/chem/materials laboratory with: a mammalian cell culture room; and synthetic organic/polymer and analytical chemistry and biochemistry capabilities (HPLC/GPC including ELSD detection for lipids, gels, qPCR etc).
